Viewing Study NCT04462406

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 2:39 PM
Ignite Modification Date: 2026-01-03 @ 5:53 PM
Study NCT ID: NCT04462406
Status: RECRUITING
Last Update Posted: 2025-11-13
First Post: 2020-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
Sponsor: ECOG-ACRIN Cancer Research Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Melanoma View
None Clinical Stage III Cutaneous Melanoma AJCC v8 View
None Clinical Stage IV Cutaneous Melanoma AJCC v8 View
None Melanoma of Unknown Primary View
None Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 View
None Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 View
None Pathologic Stage IIID Cutaneous Melanoma AJCC v8 View
None Pathologic Stage IV Cutaneous Melanoma AJCC v8 View
None Unresectable Acral Lentiginous Melanoma View
None Unresectable Melanoma View
None Unresectable Mucosal Melanoma View
Keywords: